NYSE - Nasdaq Real Time Price • USD
Quest Diagnostics Incorporated (DGX)
As of 3:36 PM EDT. Market Open.
Earnings Estimate
CURRENCY IN USD | Current Qtr. (Jun 2024) | Next Qtr. (Sep 2024) | Current Year (2024) | Next Year (2025) |
---|---|---|---|---|
No. of Analysts | 16 | 16 | 18 | 18 |
Avg. Estimate | 2.35 | 2.32 | 8.82 | 9.46 |
Low Estimate | 2.23 | 2.18 | 8.37 | 9.21 |
High Estimate | 2.49 | 2.39 | 8.96 | 9.76 |
Year Ago EPS | 2.3 | 2.22 | 8.71 | 8.82 |
Revenue Estimate
CURRENCY IN USD | Current Qtr. (Jun 2024) | Next Qtr. (Sep 2024) | Current Year (2024) | Next Year (2025) |
---|---|---|---|---|
No. of Analysts | 14 | 14 | 17 | 17 |
Avg. Estimate | 2.4B | 2.37B | 9.44B | 9.75B |
Low Estimate | 2.38B | 2.35B | 9.37B | 9.55B |
High Estimate | 2.45B | 2.39B | 9.48B | 9.91B |
Year Ago Sales | 2.25B | -- | 9.25B | 9.44B |
Sales Growth (year/est) | 6.40% | -- | 2.10% | 3.30% |
Earnings History
CURRENCY IN USD | 6/30/2023 | 9/30/2023 | 12/31/2023 | 3/31/2024 |
---|---|---|---|---|
EPS Est. | 2.27 | 2.19 | 2.11 | 1.85 |
EPS Actual | 2.3 | 2.22 | 2.15 | 2.04 |
Difference | 0.03 | 0.03 | 0.04 | 0.19 |
Surprise % | 1.30% | 1.40% | 1.90% | 10.30% |
EPS Trend
CURRENCY IN USD | Current Qtr. (Jun 2024) | Next Qtr. (Sep 2024) | Current Year (2024) | Next Year (2025) |
---|---|---|---|---|
Current Estimate | 2.35 | 2.32 | 8.82 | 9.46 |
7 Days Ago | 2.35 | 2.34 | 8.75 | 9.41 |
30 Days Ago | 2.36 | 2.35 | 8.75 | 9.41 |
60 Days Ago | 2.37 | 2.35 | 8.75 | 9.42 |
90 Days Ago | 2.29 | 2.28 | 8.99 | 9.7 |
EPS Revisions
CURRENCY IN USD | Current Qtr. (Jun 2024) | Next Qtr. (Sep 2024) | Current Year (2024) | Next Year (2025) |
---|---|---|---|---|
Up Last 7 Days | 4 | 2 | 13 | 10 |
Up Last 30 Days | 4 | 2 | 13 | 10 |
Down Last 7 Days | -- | -- | -- | -- |
Down Last 30 Days | 8 | 10 | 2 | 2 |
Growth Estimates
CURRENCY IN USD | DGX | Industry | Sector | S&P 500 |
---|---|---|---|---|
Current Qtr. | 2.20% | -- | -- | 1.50% |
Next Qtr. | 4.50% | -- | -- | 11.40% |
Current Year | 1.30% | -- | -- | 5.20% |
Next Year | 7.30% | -- | -- | 13.40% |
Next 5 Years (per annum) | 4.96% | -- | -- | 11.09% |
Past 5 Years (per annum) | 9.96% | -- | -- | -- |
Research Analysis
Upgrades & Downgrades
Maintains | Barclays: Equal-Weight to Equal-Weight | 4/25/2024 |
Maintains | Citigroup: Neutral to Neutral | 4/24/2024 |
Maintains | UBS: Neutral to Neutral | 4/24/2024 |
Maintains | Truist Securities: Hold to Hold | 4/24/2024 |
Maintains | Mizuho: Buy to Buy | 4/24/2024 |
Reiterates | Truist Securities: Hold to Hold | 3/20/2024 |
Related Tickers
LH Laboratory Corporation of America Holdings
198.27
-4.65%
DHR Danaher Corporation
246.79
-1.45%
TMO Thermo Fisher Scientific Inc.
572.33
-0.88%
MEDP Medpace Holdings, Inc.
392.12
-1.37%
ICLR ICON Public Limited Company
304.37
-1.64%
GH Guardant Health, Inc.
17.24
-4.75%
ILMN Illumina, Inc.
121.03
-1.50%
WAT Waters Corporation
309.29
-0.31%
IDXX IDEXX Laboratories, Inc.
488.92
-1.08%
A Agilent Technologies, Inc.
136.92
-0.42%